Drew Flaada is responsible for Emerging Solutions Development in IBM’s System Technology Group.  This is a small, nimble team with a mission to learn from direct interaction with the market and leading adopters.  Key focus for this team is to set the direction for IBM in Cloud computing, and to leverage our long term and deep relationships with clients in health care.  Drew founded and continues to manage IBM’s long term collaborative relationship with Mayo Clinic as a part of these responsibilities.

Drew is a board member for the BioBusiness Alliance of Minnesota, is on the Dean's Advisory Board for the University of Minnesota's Institute of Technology, and is on the University of Minnesota Rochester Biomedical Informatics and Computational Biology program advising faculty and Scientific Advisory Board. He holds a BSEE degree from North Dakota State University and an MS in Management of Technology from the University of Minnesota.

Ms. Gemmell is responsible for leading WebMD’s new business solutions for pharmaceutical, biotech and medical device clients and their affiliated agencies, as well as the sales operations team. Ms. Gemmell joined the organization in 1999 and under her leadership, the company’s sales and sales operation business has grown significantly. Her sales teams develop fully integrated solutions that leverage WebMD’s consumer properties: WebMD.com and WebMD The Magazine, and WebMD’s healthcare professional properties: Medscape.com, eMedicine.com, theheart.org and The Little Blue Book. Prior to joining WebMD, Ms. Gemmell spent almost a decade at Pharmacia (formerly The Upjohn Company). Dorothy holds a B.S. degree in biochemistry from McGill University, Montreal, Canada.

With over 20 years of experience, Ms. Giroud is founder and senior faculty board member of the World Medical Device Organization (WMDO), an independent professional organization dedicated exclusively to serving the professional development and educational needs of medical device professionals from around the world. Ms. Giroud is regarded as a recognized clinical research and regulatory expert within the medical device industry, having shared her extensive knowledge and experience with multi-national corporations and startup companies from around the globe. She is also currently convener for the expert group on clinical investigations; TC 194 WG4 for the ISO 14155 as well as liaison with the EU Commission - CIE (Clinical Investigation and Evaluation)task force.

Steve Griffiths is currently the VP of Medical Informatics consulting practice within Ingenix consulting.  He has over 17 years of experience in health analytics management, program evaluation, and consultation.  Prior to joining the Medical Management team within Ingenix, Steve served as the Sr. Director for Healthcare Analytics at OptumHealth Care Solutions.  Before coming to OptumHealth, Steve was the Director of Healthcare Informatics at Blue Cross Blue Shield of Minnesota.  Steve received a Masters degree in Biostatistics from the University of Washington and a Ph.D. in Health Services Research, Policy and Administration from the University of Minnesota.

Dr. Marie Johnson is the founder and president of AUM Cardiovascular, a company dedicated to the development of a noninvasive, hand-held, fast, extremely affordable device for the assessment of coronary artery disease. Marie holds a B.S. in mechanical engineering and a M.S. and Ph.D. in biomedical engineering. The biodesign program was her third postdoctoral fellowship and the most crucial to her dream of commercialization of AUM. Marie is also the Director of the Medical Device Innovation Fellowship at the University of Minnesota in Minneapolis. This fellowship is based upon the biodesign model.

Donald Jones serves as vice president of business development for health & life sciences at Qualcomm.  Jones is responsible for Qualcomm’s enablement of wireless technologies in the health and life sciences markets, a recognized leader in the field. In 2005, he founded the Wireless Life Sciences Alliance, a 501c(6) trade organization that works with both the wireless and life science industries to enable new business models, new businesses and clinical process improvements in all sectors of the life sciences industry, including consumer health, fitness, healthcare services, healthcare IT, pharmaceutical and medical devices. Jones holds a bachelors’ degree in biology and bio-engineering from the University of California, San Diego, a Juris Doctor from the University of San Diego and an MBA from the University of California, Irvine. Jones holds multiple patents in the use of cell phones in incentive reward programs.

Parashar joined Boston Scientific Corporation as Vice President of Global Health Economics and Reimbursement for BSC's Healthcare Strategies and Programs group in 2003. Parashar is responsible for the Company's Corporate and Site Health Economics and Reimbursement functions, chiefly focusing on the development and implementation of global strategic and reimbursement and legislative initiatives. He is also closely involved in health economics analysis and outcomes research for the Company. Prior to joining, Parashar was Deputy Director of the Hospital and Ambulatory Policy Group in the Center for Medicare Management at the Centers for Medicare & Medicaid Services (CMS). He holds a B.A. in Political Science and a Master of Public Affairs from the University of Connecticut.

Dr. Wieben is the Director of Mayo Clinic Genomics Research Center, Professor of Biochemistry and Molecular Biology at Mayo Clinic College of Medicine and the Mayo Project Leader of the Minnesota Partnership for Biotechnology and Medical Genomics. He is also on the Board of Directors of the BioBusiness Alliance of Minnesota, an industry lead non-profit group that is working to develop Biotechnology business ventures. Dr. Wieben earned a B.S. degree in Biological Sciences with highest distinction at Indiana University and a Ph.D. in Biology from Yale University. Dr. Wieben completed his post doctoral fellowship at the Worcester Foundation for Experimental Biology before joining the Department of Biochemistry and Molecular Biology (BMB) at Mayo in 1983. Dr. Wieben chaired Mayo's BMB department for 7 years before assuming his present roles. He has 12 patents and over 100 publications in the fields of medical education and research.

Dr. Woodburn is the President for Woodburn Health Consulting.  He supports start-up and established health care companies accelerate consumer-centered and consumer-driven systems change.  He has published articles in clinical outcomes measurement and results.  Dr. Woodburn has been Chief Medical Officer for MinuteClinic where he worked to develop strategic direction as well as providing clinical integrity and quality leadership. Woody also was VP, Clinical Initiatives at United Health Group/OptumHealth helping lead the launch of a national Telehealth business enterprise. He is an Emergency Medicine residency and fellowship trained physician and holds 2 engineering degrees from the University of Wisconsin-Madison.